Literature DB >> 11339975

HERG K+ channels: friend and foe.

J I Vandenberg1, B D Walker, T J Campbell.   

Abstract

The K+ channel encoded by the human ether-à-go-go related gene (HERG) is one of many ion channels that are crucial for normal action potential repolarization in cardiac myocytes. HERG encodes the pore-forming subunit of the rapid component of the delayed rectifier K+ channel, I(K(Vr)). HERG K+ channels are of considerable pharmaceutical interest as possible therapeutic targets for anti-arrhythmic agents and as the molecular target responsible for the cardiac toxicity of a wide range of pharmaceutical agents. Recent studies of the molecular basis of the promiscuity of HERG K+ channel drug binding has not only started to shed light on this tricky pharmaceutical problem but has also provided further insights into the structure and function of HERG K+ channels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11339975     DOI: 10.1016/s0165-6147(00)01662-x

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  67 in total

1.  Effects of premature stimulation on HERG K(+) channels.

Authors:  Y Lu; M P Mahaut-Smith; A Varghese; C L Huang; P R Kemp; J I Vandenberg
Journal:  J Physiol       Date:  2001-12-15       Impact factor: 5.182

Review 2.  The HERG K+ channel: progress in understanding the molecular basis of its unusual gating kinetics.

Authors:  Jamie I Vandenberg; Allan M Torres; Terence J Campbell; Philip W Kuchel
Journal:  Eur Biophys J       Date:  2003-09-10       Impact factor: 1.733

3.  Molecular basis of slow activation of the human ether-a-go-go related gene potassium channel.

Authors:  Rajesh N Subbiah; Catherine E Clarke; David J Smith; JingTing Zhao; Terence J Campbell; Jamie I Vandenberg
Journal:  J Physiol       Date:  2004-06-04       Impact factor: 5.182

4.  Profiling diverse compounds by flux- and electrophysiology-based primary screens for inhibition of human Ether-à-go-go related gene potassium channels.

Authors:  Beiyan Zou; Haibo Yu; Joseph J Babcock; Pritam Chanda; Joel S Bader; Owen B McManus; Min Li
Journal:  Assay Drug Dev Technol       Date:  2010-12       Impact factor: 1.738

5.  Mechanism of block of the hERG K+ channel by the scorpion toxin CnErg1.

Authors:  Adam P Hill; M Sunde; T J Campbell; J I Vandenberg
Journal:  Biophys J       Date:  2007-03-16       Impact factor: 4.033

6.  State dependent dissociation of HERG channel inhibitors.

Authors:  D Stork; E N Timin; S Berjukow; C Huber; A Hohaus; M Auer; S Hering
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

7.  Utilizing high throughput screening data for predictive toxicology models: protocols and application to MLSCN assays.

Authors:  Rajarshi Guha; Stephan C Schürer
Journal:  J Comput Aided Mol Des       Date:  2008-02-19       Impact factor: 3.686

8.  Localization of the ergtoxin-1 receptors on the voltage sensing domain of hERG K+ channel by AFM recognition imaging.

Authors:  Lilia A Chtcheglova; Fatmahan Atalar; Ugur Ozbek; Linda Wildling; Andreas Ebner; Peter Hinterdorfer
Journal:  Pflugers Arch       Date:  2008-02-20       Impact factor: 3.657

9.  Escitalopram block of hERG potassium channels.

Authors:  Yun Ju Chae; Ji Hyun Jeon; Hong Joon Lee; In-Beom Kim; Jin-Sung Choi; Ki-Wug Sung; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-09-18       Impact factor: 3.000

10.  Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.

Authors:  James T Milnes; Olivia Crociani; Annarosa Arcangeli; Jules C Hancox; Harry J Witchel
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.